Clinical trial
Vortex - First in Human Study to Evaluate the Feasibility, Safety, Clinical and Technical Success of the Vortex Temporary Percutaneous, Transvalvular Circulatory Support System (Vortex System)
NCT04674111 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vortex - First in Human Study to Evaluate the Feasibility, Safety, Clinical and Technical Success of the Vortex Temporary Percutaneous, Transvalvular Circulatory Support System (Vortex System)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 28, 2021
- Completion date
- April 8, 2022
- Enrollment
- 5 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.